Showing results (1-10 of 400) with videos related to

Sort By:
Pageof 40
Advances in Therapy|May 15, 2024
Does an Aspirin a Day Take the MASLD Away?Amedeo Lonardo, Ming-Hua Zheng
Gut Microbes|October 10, 2023
Microbial-host-isozyme: unveiling a new era in microbiome-host interactionLei Miao, Herbert Tilg, Ming-Hua Zheng
Oncology and Therapy|May 15, 2026
Repurposing Resmetirom to Suppress MASLD/MASH-HCC in the Dysmetabolic EraAmedeo Lonardo, Ming-Hua Zheng, Ralf Weiskirchen
Expert Review of Gastroenterology & Hepatology|August 8, 2025
Food insecurity is an emerging risk factor for liver disease: a scoping reviewAmedeo Lonardo, Ming-Hua Zheng, Ralf Weiskirchen
Chinese Medical Journal|December 2, 2021
Non-alcoholic steatohepatitis and risk of hepatocellular carcinomaRafael S Rios, Kenneth I Zheng, Ming-Hua Zheng
Expert Review of Gastroenterology & Hepatology|August 27, 2020
Data sharing during COVID-19 pandemic: what to take awayRafael S Rios, Kenneth I Zheng, Ming-Hua Zheng
Clinical and Molecular Hepatology|November 29, 2022
MAFLD: How is it different from NAFLD?Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, et al.
Cytotherapy|January 8, 2010
Liver tissue engineering: promises and prospects of new technologyMing-Hua Zheng, Chao Ye, Martin Braddock, et al.
Pageof 40